Holman Division of Endocrinology, Diabetes & Metabolism Publications
Research conducted by NYU Langone’s Holman Division of Endocrinology, Diabetes, and Metabolism appears in leading academic and medical publications.
Recipients of the 2024 Early Career Investigator Awards
Arteriosclerosis, thrombosis, & vascular biology. 2024 May ; 44:1001
International Diabetes Federation Position Statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes
Diabetes research & clinical practice. 2024 Mar ; 209:111589
Burden of cardiometabolic risk factors and vascular health
American heart journal. 2024 Mar ; 269:201-204
Circ_ST6GAL1-mediated competing endogenous RNA network regulates TGF-β1-stimulated matrix Metalloproteinase-13 expression via Runx2 acetylation in osteoblasts
Non-coding RNA research. 2024 Mar ; 9:153-164
Inclusion of Sex and Gender Differences in U.S. State Action Plans for Opioid Use and Opioid Use Disorder
Journal of women's health (Larchmont, N.Y. : 2002). 2024 Mar ; 33:275-282
The RAGE/DIAPH1 axis: mediator of obesity and proposed biomarker of human cardiometabolic disease
Cardiovascular research. 2024 Feb 17; 119:2813-2824
Cardiometabolic disease: linking pathogenic mechanisms to therapeutic opportunities
Cardiovascular research. 2024 Feb 17; 119:2771-2773
Continuous glucose monitoring captures glycemic variability in obesity after sleeve gastrectomy: A prospective cohort study
Obesity science & practice. 2024 Feb 01; 10:?-?